Browse

Previously we have developed the PLGA nanoparticles loaded with doxorubicin (PLGA-DOX NP) that demonstrated a high anti-tumor effect against the rat glioblastoma in the preclinical studies and is now being evaluated in the clinical phase II study. This formulation was obtained by a generally accepted homogenization ? solvent evaporation technique followed by freeze-drying. The purpose of the present study was to explore the feasibility to simplify the process of the nanoparticle preparation by replacing a freeze d...